Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.

McGeer PL, McGeer EG.

Acta Neuropathol. 2013 Oct;126(4):479-97. doi: 10.1007/s00401-013-1177-7. Epub 2013 Sep 20. Review.

PMID:
24052108
2.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
3.

[Alzheimer disease: cellular and molecular aspects].

Octave JN.

Bull Mem Acad R Med Belg. 2005;160(10-12):445-9; discussion 450-1. French.

PMID:
16768248
4.

[Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].

Kuzuhara S.

Brain Nerve. 2010 Jul;62(7):659-66. Review. Japanese.

PMID:
20675870
5.

[Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].

Xu BG, Wu X.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Apr;26(2):201-9. Review. Chinese.

PMID:
15171563
6.

Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.

Lee M, McGeer E, McGeer PL.

Neurobiol Aging. 2015 Jan;36(1):42-52. doi: 10.1016/j.neurobiolaging.2014.07.024. Epub 2014 Jul 24.

PMID:
25169677
7.

[Therapy of Alzheimer disease].

Kovács T.

Neuropsychopharmacol Hung. 2009 Mar;11(1):27-33. Review. Hungarian.

8.

Efficacy of a therapeutic vaccine using mutated β-amyloid sensitized dendritic cells in Alzheimer's mice.

Luo Z, Li J, Nabar NR, Lin X, Bai G, Cai J, Zhou SF, Cao C, Wang J.

J Neuroimmune Pharmacol. 2012 Sep;7(3):640-55. doi: 10.1007/s11481-012-9371-2. Epub 2012 Jun 9.

PMID:
22684353
9.

An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ.

Adolfsson O, Pihlgren M, Toni N, Varisco Y, Buccarello AL, Antoniello K, Lohmann S, Piorkowska K, Gafner V, Atwal JK, Maloney J, Chen M, Gogineni A, Weimer RM, Mortensen DL, Friesenhahn M, Ho C, Paul R, Pfeifer A, Muhs A, Watts RJ.

J Neurosci. 2012 Jul 11;32(28):9677-89. doi: 10.1523/JNEUROSCI.4742-11.2012.

10.

Why pleiotropic interventions are needed for Alzheimer's disease.

Frautschy SA, Cole GM.

Mol Neurobiol. 2010 Jun;41(2-3):392-409. doi: 10.1007/s12035-010-8137-1. Epub 2010 May 2. Review.

11.

[Involvement of beta-amyloid in the etiology of Alzheimer's disease].

Tomiyama T.

Brain Nerve. 2010 Jul;62(7):691-9. Review. Japanese.

PMID:
20675873
12.

Disease-modifying therapies in Alzheimer's disease: how far have we come?

Hüll M, Berger M, Heneka M.

Drugs. 2006;66(16):2075-93. Review.

PMID:
17112302
13.

Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.

Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, Greco A, Seripa D, Pilotto A.

Immunotherapy. 2012 Feb;4(2):213-38. doi: 10.2217/imt.11.170. Review.

PMID:
22339463
14.

The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation.

Potter H, Wefes IM, Nilsson LN.

Neurobiol Aging. 2001 Nov-Dec;22(6):923-30. Review.

PMID:
11755000
15.

Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.

Matsuo K, Okamoto H, Kawai Y, Quan YS, Kamiyama F, Hirobe S, Okada N, Nakagawa S.

J Neuroimmunol. 2014 Jan 15;266(1-2):1-11. doi: 10.1016/j.jneuroim.2013.11.002. Epub 2013 Nov 11.

PMID:
24315156
16.

Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.

Blasko I, Grubeck-Loebenstein B.

Drugs Aging. 2003;20(2):101-13. Review.

PMID:
12534311
17.

Alzheimer's disease and amyloid: culprit or coincidence?

Skaper SD.

Int Rev Neurobiol. 2012;102:277-316. doi: 10.1016/B978-0-12-386986-9.00011-9. Review.

PMID:
22748834
18.

Amyloid-beta (Aβ) D7H mutation increases oligomeric Aβ42 and alters properties of Aβ-zinc/copper assemblies.

Chen WT, Hong CJ, Lin YT, Chang WH, Huang HT, Liao JY, Chang YJ, Hsieh YF, Cheng CY, Liu HC, Chen YR, Cheng IH.

PLoS One. 2012;7(4):e35807. doi: 10.1371/journal.pone.0035807. Epub 2012 Apr 30.

19.

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.

Chen Z, Zhong C.

Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11. Review.

20.

Always around, never the same: pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease.

Hoozemans JJ, Chafekar SM, Baas F, Eikelenboom P, Scheper W.

Curr Med Chem. 2006;13(22):2599-605. Review.

PMID:
17017913

Supplemental Content

Support Center